Table 1 The distribution of histologic alterations within the groups
From: Do histopathologic findings improve by increasing the sample size in cholecystectomies?
Group 1 (n/%) | Group 2 (n/%) | P | Kappa | |
|---|---|---|---|---|
Acute cholecystitis | 31 (7.2%) | 31 (7.2%) | >0.05 | 0.965 |
Chronic cholecystitis | 401 (92.8%) | 401 (92.8%) | ||
Non-cholesterolosis | 337 (78%) | 324 (75%) | 0.001 | 0.904 |
Cholesterolosis | 95 (22%) | 108 (25%) | ||
Non-metaplasia | 407 (94.2%) | 391 (91.2%) | 0.0001 | 0.739 |
Pyloric metaplasia | 23 (5.3%) | 38 (8.8%) | ||
Intestinal metaplasia | 2 (0.5%) | 3 (0.7%) | ||
Non-polyp | 422 (97.8%) | 416 (96.6%) | 0.031 | 0.76 |
Cholesterol polyp | 7 (1.6%) | 11 (2.5%) | ||
Fibroepithelial polyp | 1 (0.2%) | 2 (0.5%) | ||
Tubular adenoma | 1 (0.2%) | 1 (0.2%) | ||
Papillary adenoma | 1 (0.2%) | 1 (0.2%) | ||
Non-dysplasia | 430 (99.5%) | 430 (99.5%) | >0.05 | 1.0 |
Low grade dysplasia | 2 (0.5%) | 2 (0.5%) | ||
High grade dysplasia | 0 (0%) | 0 (0%) | ||
Carcinoma | 0 (0%) | 0 (0%) | >0.05 | 1.0 |